logo-loader
RNS
viewOmega Diagnostics Group Plc

Update on Allergy test menu

/**/ h1{margin-right:0cm;margin-left:0cm;font-size:24.0pt;font-family:"Times New Roman","serif";font-weight:bold;}h2{margin-right:0cm;margin-left:0cm;font-size:18.0pt;font-family:"Times New Roman","serif";font-weight:bold;}h3{margin-right:0cm;margin-left:0cm;font-size:13.5pt;font-family:"Times New Roman","serif";font-weight:bold;}h4{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight:bold;}h5{margin-right:0cm;margin-left:0cm;font-size:10.0pt;font-family:"Times New Roman","serif";font-weight:bold;}h6{margin-top:0cm;margin-right:41.3pt;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:justify;font-size:10.0pt;font-family:"Arial","sans-serif";color:black;font-weight:bold;}p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: blue } visited{ color: purple } .cc{size:612.0pt 792.0pt;margin:2.0cm 42.55pt 2.0cm 42.55pt;}div.cc{}p.dj{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; text-align: center}span.dh{font-size:10.0pt;font-family:"Arial","sans-serif"}span.df{font-size:11.0pt;font-family:"Calibri","sans-serif"}p.dk{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.de{font-size:11.0pt;font-family:"Calibri","sans-serif";color:black}span.dc{font-size:11.0pt; font-family:"Calibri","sans-serif"}span.db{font-family:"Calibri","sans-serif";color:black}p.dl{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-div: italic; text-align: center} p.dm{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin-right: 41.3pt; text-align: justify}table.dn{margin-left:-5.4pt;border-collapse:collapse}tr.cu{height:11.45pt}td.cx{width:222.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:11.45pt}p.do{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; text-align: justify}td.cv{width:280.85pt;padding:0cm 5.4pt 0cm 5.4pt; height:11.45pt}p.dp{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align: right}tr.cr{height:12.0pt}td.ct{width:222.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:12.0pt}td.cs{width:280.85pt;padding:0cm 5.4pt 0cm 5.4pt; height:12.0pt} tr.co{height:9.6pt}td.cq{width:222.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:9.6pt}td.cp{width:280.85pt;padding:0cm 5.4pt 0cm 5.4pt; height:9.6pt}tr.cl{height:4.5pt}td.cn{width:222.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:4.5pt}td.cm{width:280.85pt;padding:0cm 5.4pt 0cm 5.4pt; height:4.5pt}tr.ci{height:5.4pt}td.ck{width:222.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:5.4pt}td.cj{width:280.85pt;padding:0cm 5.4pt 0cm 5.4pt; height:5.4pt}tr.cf{height:4.0pt} td.ch{width:222.05pt;padding:0cm 5.4pt 0cm 5.4pt; height:4.0pt}td.cg{width:280.85pt;padding:0cm 5.4pt 0cm 5.4pt; height:4.0pt}p.dq{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify;text-autospace:none} /**/
RNS Number : 4455U
Omega Diagnostics Group PLC
25 November 2019
 

 

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Update on Allergy test menu

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked its first allergy screening assay to be run on the IDS-iSYS automated instrument.

 

The assay uses a mix of five different single allergens and is the first mix in a planned programme to develop a range of mixes to meet market needs. Screening assays, which contain multiple allergens, are a useful tool in helping to efficiently diagnose the causes of patient allergies.

 

Colin King, CEO of the Company, said: "The Grass mix is the first of five mixes required to enhance our Allergy panel and further demonstrates our excellent development capability. We will continue to focus our efforts to bring the remaining assays to the market, which will allow us to be more commercially competitive."

 

 

 

Contacts: 

 

Omega Diagnostics Group PLC                         

Tel: 01259 763 030

Bill Rhodes, Interim Non-Executive Chairman

Colin King, Chief Executive                             

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

 

 

 

finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/Hannah Boros (Corporate Finance)

 

Camille Gochez (ECM)

 

 

 

Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
UPDPGGCWGUPBGRC

Quick facts: Omega Diagnostics Group Plc

Price: 15.5

Market: AIM
Market Cap: £23.3 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE